Total Payments
$3,485
2024 Payments
$925.24
Companies
13
Transactions
87
Medicare Patients
121
Medicare Billing
$12,901
Payment Breakdown by Category
Food & Beverage$3,450 (99.0%)
Education$34.18 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,450 | 84 | 99.0% |
| Education | $34.18 | 3 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,012 | 26 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $692.71 | 14 | $0 (2024) |
| Alkermes, Inc. | $686.19 | 15 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $302.79 | 3 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $279.51 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $212.59 | 3 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $154.58 | 12 | $0 (2017) |
| Shire North American Group Inc | $53.61 | 4 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $23.94 | 2 | $0 (2017) |
| Axsome Therapeutics, Inc. | $19.66 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $925.24 | 16 | Otsuka America Pharmaceutical, Inc. ($296.21) |
| 2023 | $368.07 | 7 | Neurocrine Biosciences, Inc. ($204.31) |
| 2022 | $678.04 | 7 | Otsuka America Pharmaceutical, Inc. ($263.02) |
| 2021 | $320.04 | 3 | Janssen Pharmaceuticals, Inc ($225.85) |
| 2020 | $213.45 | 3 | Otsuka America Pharmaceutical, Inc. ($119.06) |
| 2019 | $289.82 | 5 | Alkermes, Inc. ($179.54) |
| 2018 | $165.61 | 7 | Janssen Pharmaceuticals, Inc ($112.27) |
| 2017 | $524.38 | 39 | Sunovion Pharmaceuticals Inc. ($154.58) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $91.49 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/22/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $96.60 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $32.93 | General |
| Category: CNS | ||||||
| 10/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 09/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $93.83 | General |
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Neurology | ||||||
| 09/12/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $69.41 | General |
| Category: Neuroscience | ||||||
| 09/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $45.04 | General |
| Category: Neuroscience | ||||||
| 09/03/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Neurology | ||||||
| 08/08/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $123.23 | General |
| Category: Neurology | ||||||
| 05/09/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Neuroscience | ||||||
| 04/03/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $124.90 | General |
| Category: PSYCHIATRY | ||||||
| 02/16/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 01/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: PSYCHIATRY | ||||||
| 12/14/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/07/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: PSYCHIATRY | ||||||
| 10/26/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $103.17 | General |
| Category: Neuropsychiatry | ||||||
| 10/24/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: PSYCHIATRY | ||||||
| 04/27/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $92.53 | General |
| Category: PSYCHIATRY | ||||||
| 02/22/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $101.14 | General |
| Category: Neuropsychiatry | ||||||
| 01/04/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: PSYCHIATRY | ||||||
| 10/27/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $98.48 | General |
| Category: Neuropsychiatry | ||||||
| 10/25/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $124.86 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 69 | 149 | $17,685 | $6,898 |
| 2021 | 1 | 19 | 45 | $3,825 | $1,317 |
| 2020 | 2 | 33 | 83 | $12,277 | $4,686 |
Total Patients
121
Total Services
277
Medicare Billing
$12,901
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 33 | 113 | $9,605 | $3,356 | 34.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 19 | 19 | $5,700 | $2,612 | 45.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 17 | 17 | $2,380 | $929.05 | 39.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 19 | 45 | $3,825 | $1,317 | 34.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 20 | 60 | $9,540 | $3,579 | 37.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 23 | $2,737 | $1,107 | 40.5% |
About Dr. Kenneth Fattmann, MD
Dr. Kenneth Fattmann, MD is a Psychiatry healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1922129170.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Fattmann, MD has received a total of $3,485 in payments from pharmaceutical and medical device companies, with $925.24 received in 2024. These payments were reported across 87 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($3,450).
As a Medicare-enrolled provider, Fattmann has provided services to 121 Medicare beneficiaries, totaling 277 services with total Medicare billing of $12,901. Data is available for 3 years (2020–2022), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Springfield, MO
- Active Since 04/03/2007
- Last Updated 03/22/2019
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1922129170
Products in Payments
- ABILIFY MAINTENA (Drug) $554.95
- REXULTI (Drug) $456.56
- SPRAVATO (Drug) $416.68
- ARISTADA (Drug) $384.97
- INGREZZA (Drug) $302.79
- INVEGA SUSTENNA (Drug) $259.58
- LYBALVI (Drug) $193.31
- UZEDY (Drug) $156.28
- LATUDA (Drug) $154.58
- AUSTEDO (Drug) $123.23
- COBENFY (Drug) $118.76
- Aristada 441 mg (Drug) $107.91
- VYVANSE (Drug) $29.11
- MYDAYIS (Drug) $24.50
- Auvelity (Drug) $19.66
- Trintellix (Drug) $16.63
- INVEGA TRINZA (Drug) $16.45
- PERSERIS (Drug) $16.08
- VRAYLAR (Drug) $14.85
- BELSOMRA (Drug) $12.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Springfield
Dr. Kalpana Vishnupad, M.d, M.D
Psychiatry — Payments: $63,945
Psychiatry $63,945
Dr. Andrea Stonecipher, M.d, M.D
Psychiatry — Payments: $28,609
Psychiatry $28,609
Dr. Shirlann Knight, M.d, M.D
Psychiatry — Payments: $9,255
Psychiatry $9,255
Dr. Umamaheswara Vellanki, M.d, M.D
Psychiatry — Payments: $9,082
Psychiatry $9,082
Dr. Dennis Dobard, M.d, M.D
Psychiatry — Payments: $8,804
Psychiatry $8,804
Dr. Obiora Onwuameze, Md, Ms, Phd, MD, MS, PHD
Psychiatry — Payments: $6,358
Psychiatry $6,358